Time in Target Range for Systolic Blood Pressure and Cardiovascular Outcomes in Patients With Heart Failure With Preserved Ejection Fraction
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Time in Target Range for Systolic Blood Pressure and Cardiovascular Outcomes in Patients With Heart Failure With Preserved Ejection Fraction
Authors
Keywords
-
Journal
Journal of the American Heart Association
Volume 11, Issue 7, Pages -
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2022-03-15
DOI
10.1161/jaha.121.022765
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Association of long-term SBP with clinical outcomes and quality of life in heart failure with preserved ejection fraction
- (2021) Peisen Huang et al. JOURNAL OF HYPERTENSION
- Systolic Blood Pressure Time in Target Range and Cardiovascular Outcomes in Patients With Hypertension
- (2021) Nayyra Fatani et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Trends in prevalence of comorbidities in heart failure clinical trials
- (2020) Muhammad Shahzeb Khan et al. EUROPEAN JOURNAL OF HEART FAILURE
- Systolic Blood Pressure in Heart Failure With Preserved Ejection Fraction Treated With Sacubitril/Valsartan
- (2020) Senthil Selvaraj et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Evaluation and management of heart failure with preserved ejection fraction
- (2020) Barry A. Borlaug Nature Reviews Cardiology
- 2020 International Society of Hypertension Global Hypertension Practice Guidelines
- (2020) Thomas Unger et al. HYPERTENSION
- Influence of polypharmacy on patients with heart failure with preserved ejection fraction: a retrospective analysis on adverse outcomes in the TOPCAT trial
- (2020) Yuzhong Wu et al. BRITISH JOURNAL OF GENERAL PRACTICE
- Systolic Blood Pressure and Outcomes in Patients With Heart Failure With Preserved Ejection Fraction
- (2018) Apostolos Tsimploulis et al. JAMA Cardiology
- Systolic blood pressure and cardiovascular outcomes in heart failure with preserved ejection fraction: an analysis of the TOPCAT trial
- (2017) Senthil Selvaraj et al. EUROPEAN JOURNAL OF HEART FAILURE
- Pharmacist-physician collaborative care model and time to goal blood pressure in the uninsured population
- (2017) Dave L. Dixon et al. Journal of Clinical Hypertension
- Time in Therapeutic Range, as a Determinant of All‐Cause Mortality in Patients With Hypertension
- (2017) Michael Doumas et al. Journal of the American Heart Association
- Reverse J-Curve Relationship Between On-Treatment Blood Pressure and Mortality in Patients With Heart Failure
- (2017) Sang Eun Lee et al. JACC-Heart Failure
- Treatment of high blood pressure in elderly and octogenarians: European Society of Hypertension statement on blood pressure targets
- (2016) Sverre E Kjeldsen et al. BLOOD PRESSURE
- The pathophysiology of heart failure with preserved ejection fraction
- (2014) Barry A. Borlaug Nature Reviews Cardiology
- Spironolactone for Heart Failure with Preserved Ejection Fraction
- (2014) Bertram Pitt et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started